Two Cancers, One Gene. Why Some People in Families Develop Melanoma or Pancreas Cancer, While Still Others Never Develop Cancer.
- Status
- COMPLETED
- Phase
- N/A
Clinical Trials Related to Melanoma
Related studies linked through entity extraction aliases.
Exercise as a Supportive Measure for Patients Undergoing Checkpoint-inhibitor Treatment
- Status
- COMPLETED
- Phase
- PHASE2
Melanomas Excised in Primary Care vs Secondary Care Excision
- Status
- COMPLETED
- Phase
- N/A
QUILT-3.046: NANT Melanoma Vaccine: Combination Immunotherapy in Subjects With Melanoma Who Have Progressed On or After Chemotherapy and PD-1/PD-L1 Therapy
- Status
- WITHDRAWN
- Phase
- PHASE1/PHASE2
A Real-World Study of Ipilimumab Treatment After Nivolumab Treatment in Melanoma in Japan
- Status
- COMPLETED
- Phase
- N/A
Cost of Adverse Events Related to How Often Follow-Up Occurs Among Patients With Cancer That Has Spread
- Status
- COMPLETED
- Phase
- N/A
Feedback in the Consultation - a Dialogue-based Tool in Personalised Care Planning Using Systematic Patient Involvement
- Status
- COMPLETED
- Phase
- NA
Evaluation of Denosumab in Combination With Immune Checkpoint Inhibitors in Patients With Unresectable or Metastatic Melanoma
- Status
- UNKNOWN
- Phase
- PHASE1/PHASE2
Pfizer PF-06688992 in Patients With Stage III or Stage IV Melanoma
- Status
- COMPLETED
- Phase
- PHASE1
A Study of Adult Participants With BRAF V600 Mutation-Positive Advanced Melanoma Treated With Cobimetinib (Cotellic®) During the French Early Access Program (Temporary Authorization for Use [TAU])
- Status
- COMPLETED
- Phase
- N/A
MAGE-A4ᶜ¹º³²T for Multi-Tumor
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
SAbR Plus Ipilimumab Plus Nivolumab in Metastatic Melanoma Patients
- Status
- WITHDRAWN
- Phase
- PHASE2
CD40 Agonistic Antibody APX005M (Sotigalimab) in Combination With Nivolumab
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Dose Finding Study of TNO155 in Adult Patients With Advanced Solid Tumors
- Status
- TERMINATED
- Phase
- PHASE1
Low-dose Interleukin-2 and Pembrolizumab in Melanoma and Renal Cell Cancer
- Status
- WITHDRAWN
- Phase
- PHASE1/PHASE2
Investigating the Clinical Utility of the MDS
- Status
- COMPLETED
- Phase
- N/A
LY3022855 With BRAF/MEK Inhibition in Patients With Melanoma
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Immunotherapy Study of Evofosfamide in Combination With Ipilimumab
- Status
- UNKNOWN
- Phase
- PHASE1
Rh-endostatin in Combination With Dacarbazine and Cisplatin as the First Line Therapy for Metastatic Melanoma
- Status
- UNKNOWN
- Phase
- PHASE2
Dendritic Cell Vaccination in Patients With Advanced Melanoma
- Status
- COMPLETED
- Phase
- PHASE1